A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris

Clinical trial NCT01501799 · COMPLETED

Trial details

NCT number

NCT01501799

Sponsor

Actavis Mid-Atlantic LLC

Status

COMPLETED

Phase

Not Applicable

Study type

INTERVENTIONAL

Start date

2011-07-01

Primary completion

2011-12-01

Enrollment

885

View on ClinicalTrials.gov